Corbus Pharmaceuticals Holdings Inc. Stock Rallies 4.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. advanced 4.9% to $7.26 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 25,978.42 and the Dow Jones Industrial Average falling 1.2% to 51,461.90.

The stock's rise snapped an eight-day losing streak.

Corbus Pharmaceuticals Holdings Inc. closed 64.7% below its 52-week high of $20.56, which the company reached on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 0.2% to $5.00, Fortress Biotech Inc. fell 1.2% to $2.46, and Viking Therapeutics Inc. fell 1.44% to $29.52.

Trading volume totaled 1.2 million, compared to the 50-day average of 703,035.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 16, 2026 16:34 ET (20:34 GMT)